HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
Open Access
- 14 September 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (24) , 4542-4554
Abstract
HDAC5 is a class IIa histone deacetylase member that is downregulated in multiple solid tumors, including pancreatic cancer, and loss of HDAC5 is associated with unfavorable prognosis. In this study, assessment of The Cancer Genome Atlas pancreatic adenocarcinoma dataset revealed that expression of HDAC5 correlates negatively with arachidonic acid (AA) metabolism, which has been implicated in inflammatory responses and cancer progression. Nontargeted metabolomics analysis revealed that HDAC5 knockdown resulted in a significant increase in AA and its downstream metabolites, such as eicosanoids and prostaglandins. HDAC5 negatively regulated the expression of the gene encoding calcium-dependent phospholipase A2 (cPLA2), the key enzyme in the production of AA from phospholipids. Mechanistically, HDAC5 repressed cPLA2 expression via deacetylation of GATA1. HDAC5 knockdown in cancer cells enhanced sensitivity to genetic or pharmacologic inhibition of cPLA2 in vitro and in vivo. Fatty acid supplementation in the diet reversed the sensitivity of HDAC5-deficient tumors to cPLA2 inhibition. These data indicate that HDAC5 loss in pancreatic cancer results in the hyperacetylation of GATA1, enabling the upregulation of cPLA2, which contributes to overproduction of AA. Dietary management plus cPLA2-targeted therapy could serve as a viable strategy for treating HDAC5-deficient pancreatic cancer patients. Significance: The HDAC5-GATA1-cPLA2-AA signaling axis regulates sensitivity to fat restriction plus cPLA2 inhibition in pancreatic ductal adenocarcinoma, proposing dietary management as a feasible strategy for treating a subset of patients with pancreatic cancer.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82102794)
- National Natural Science Foundation of China (82072178)
- National Natural Science Foundation of China (81872116)
This publication has 35 references indexed in Scilit:
- Human pancreatic adenocarcinoma contains a side population resistant to gemcitabineBMC Cancer, 2012
- Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genesProceedings of the National Academy of Sciences, 2011
- Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose HomeostasisCell, 2011
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Phospholipase A2 structure/function, mechanism, and signalingJournal of Lipid Research, 2009
- Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylasesProceedings of the National Academy of Sciences of the United States of America, 2007
- Acetylation of GATA-1 is required for chromatin occupancyBlood, 2006
- Proteomics profiling of nuclear proteins for kidney fibroblasts suggests hypoxia, meiosis, and cancer may meet in the nucleusProteomics, 2005
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Group II and IV phospholipase A 2 are produced in human pancreatic cancer cells and influence prognosisGut, 1999